Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Q Therapeutics, Inc.

Clinical trials sponsored by Q Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Spinal cord repair: could cell injections restore function in transverse myelitis? Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Spinal cord repair: could cell injections restore function in transverse myelitis?

Disease control Recruiting now

This early-stage trial tests the safety of injecting Q-Cells, a type of human glial progenitor cell, directly into spinal cord lesions in people with transverse myelitis. The study enrolls up to 9 adults aged 18–70 who have had the condition for at least 3 months. Researchers wil…

Phase 1/2 • Sponsor: Q Therapeutics, Inc. • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC